Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Expression of TNF by stimulated human peripheral blood mononuclear cells (PBMC). Human PBMC were stimulated for 6 hours with PMA (50 ng/ml final concentration; Sigma) and calcium ionophore A23187 (1 µg/ml final concentration; Sigma), in the presence of GolgiStop™ (2 µM final concentration; Cat. No. 554724). The PMBC were stained with FITC-anti-CD3 (FITC-UCHT1, Cat. No. 555332), fixed, permeabilized, and subsequently stained with 0.125 µg of APC-mouse anti-human TNF (APC-MAb11, Cat. No. 554514, left panel) or with 0.125 µg APC-mouse IgG1 (Cat. No. 554681, right panel) using BD Pharmingen™ staining protocol. To demonstrate specificity, the binding of APC-MAb11 antibody was blocked by perincubation of fixed/permabilized cells with excess unlabelled MAb11 antibody (5 µg; Cat. No. 554510). The quadrant markers for the bivariate dot plot were set based on isotype controls and verified using the unlabelled MAb11 antibody blocking control. The APC-conjugated reagent can be used in any flow cytometer equipped with a dye, HeNE or red diode laser. These include the dual laser FACStarPLUS™, FACSVantage™, or FACSCalibur™.
Expression of TNF by stimulated human peripheral blood mononuclear cells (PBMC). Human PBMC were stimulated for 6 hours with PMA (50 ng/ml final concentration; Sigma) and calcium ionophore A23187 (1 µg/ml final concentration; Sigma), in the presence of GolgiStop™ (2 µM final concentration; Cat. No. 554724). The PMBC were stained with FITC-anti-CD3 (FITC-UCHT1, Cat. No. 555332), fixed, permeabilized, and subsequently stained with 0.125 µg of APC-mouse anti-human TNF (APC-MAb11, Cat. No. 554514, left panel) or with 0.125 µg APC-mouse IgG1 (Cat. No. 554681, right panel) using BD Pharmingen™ staining protocol. To demonstrate specificity, the binding of APC-MAb11 antibody was blocked by perincubation of fixed/permabilized cells with excess unlabelled MAb11 antibody (5 µg; Cat. No. 554510). The quadrant markers for the bivariate dot plot were set based on isotype controls and verified using the unlabelled MAb11 antibody blocking control. The APC-conjugated reagent can be used in any flow cytometer equipped with a dye, HeNE or red diode laser. These include the dual laser FACStarPLUS™, FACSVantage™, or FACSCalibur™.
Expression of TNF by stimulated human peripheral blood mononuclear cells (PBMC). Human PBMC were stimulated for 6 hours with PMA (50 ng/ml final concentration; Sigma) and calcium ionophore A23187 (1 µg/ml final concentration; Sigma), in the presence of GolgiStop™ (2 µM final concentration; Cat. No. 554724). The PMBC were stained with FITC-anti-CD3 (FITC-UCHT1, Cat. No. 555332), fixed, permeabilized, and subsequently stained with 0.125 µg of APC-mouse anti-human TNF (APC-MAb11, Cat. No. 554514, left panel) or with 0.125 µg APC-mouse IgG1 (Cat. No. 554681, right panel) using BD Pharmingen™ staining protocol. To demonstrate specificity, the binding of APC-MAb11 antibody was blocked by perincubation of fixed/permabilized cells with excess unlabelled MAb11 antibody (5 µg; Cat. No. 554510). The quadrant markers for the bivariate dot plot were set based on isotype controls and verified using the unlabelled MAb11 antibody blocking control. The APC-conjugated reagent can be used in any flow cytometer equipped with a dye, HeNE or red diode laser. These include the dual laser FACStarPLUS™, FACSVantage™, or FACSCalibur™.
Expression of TNF by stimulated human peripheral blood mononuclear cells (PBMC). Human PBMC were stimulated for 6 hours with PMA (50 ng/ml final concentration; Sigma) and calcium ionophore A23187 (1 µg/ml final concentration; Sigma), in the presence of GolgiStop™ (2 µM final concentration; Cat. No. 554724). The PMBC were stained with FITC-anti-CD3 (FITC-UCHT1, Cat. No. 555332), fixed, permeabilized, and subsequently stained with 0.125 µg of APC-mouse anti-human TNF (APC-MAb11, Cat. No. 554514, left panel) or with 0.125 µg APC-mouse IgG1 (Cat. No. 554681, right panel) using BD Pharmingen™ staining protocol. To demonstrate specificity, the binding of APC-MAb11 antibody was blocked by perincubation of fixed/permabilized cells with excess unlabelled MAb11 antibody (5 µg; Cat. No. 554510). The quadrant markers for the bivariate dot plot were set based on isotype controls and verified using the unlabelled MAb11 antibody blocking control. The APC-conjugated reagent can be used in any flow cytometer equipped with a dye, HeNE or red diode laser. These include the dual laser FACStarPLUS™, FACSVantage™, or FACSCalibur™.
Expression of TNF by stimulated human peripheral blood mononuclear cells (PBMC). Human PBMC were stimulated for 6 hours with PMA (50 ng/ml final concentration; Sigma) and calcium ionophore A23187 (1 µg/ml final concentration; Sigma), in the presence of GolgiStop™ (2 µM final concentration; Cat. No. 554724). The PMBC were stained with FITC-anti-CD3 (FITC-UCHT1, Cat. No. 555332), fixed, permeabilized, and subsequently stained with 0.125 µg of APC-mouse anti-human TNF (APC-MAb11, Cat. No. 554514, left panel) or with 0.125 µg APC-mouse IgG1 (Cat. No. 554681, right panel) using BD Pharmingen™ staining protocol. To demonstrate specificity, the binding of APC-MAb11 antibody was blocked by perincubation of fixed/permabilized cells with excess unlabelled MAb11 antibody (5 µg; Cat. No. 554510). The quadrant markers for the bivariate dot plot were set based on isotype controls and verified using the unlabelled MAb11 antibody blocking control. The APC-conjugated reagent can be used in any flow cytometer equipped with a dye, HeNE or red diode laser. These include the dual laser FACStarPLUS™, FACSVantage™, or FACSCalibur™.
Expression of TNF by stimulated human peripheral blood mononuclear cells (PBMC). Human PBMC were stimulated for 6 hours with PMA (50 ng/ml final concentration; Sigma) and calcium ionophore A23187 (1 µg/ml final concentration; Sigma), in the presence of GolgiStop™ (2 µM final concentration; Cat. No. 554724). The PMBC were stained with FITC-anti-CD3 (FITC-UCHT1, Cat. No. 555332), fixed, permeabilized, and subsequently stained with 0.125 µg of APC-mouse anti-human TNF (APC-MAb11, Cat. No. 554514, left panel) or with 0.125 µg APC-mouse IgG1 (Cat. No. 554681, right panel) using BD Pharmingen™ staining protocol. To demonstrate specificity, the binding of APC-MAb11 antibody was blocked by perincubation of fixed/permabilized cells with excess unlabelled MAb11 antibody (5 µg; Cat. No. 554510). The quadrant markers for the bivariate dot plot were set based on isotype controls and verified using the unlabelled MAb11 antibody blocking control. The APC-conjugated reagent can be used in any flow cytometer equipped with a dye, HeNE or red diode laser. These include the dual laser FACStarPLUS™, FACSVantage™, or FACSCalibur™.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Immunofluorescent Staining and Flow Cytometric Analysis: The APC-MOPC-21 immunoglobulin (Cat. No. 554681) is a suitable mouse IgG1 isotype control for assessing the level of background staining on paraformaldehyde fixed/saponin-permeabilized mouse or human cells for flow cytometric analysis. Use at comparable concentrations to antibody of interest (e.g., ≤ 0.5 µg mAb/1 million cells) (see figure). For specific methodology, visit the protocols section of our website, or refer to the Immune Function Handbook, which is posted on our web site at www.bdbiosciences.com
The MOPC-21 immunoglobulin is a mouse myeloma protein. The MOPC-21 immunoglobulin was selected as an isotype control following screening for low background on a variety of mouse and human tissues.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.